Eyeworld Daily News

2022 EyeWorld Daily News Friday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/1465478

Contents of this Issue


Page 0 of 74

D A I LY N E W S ASCRS F R I DAY, A P R I L 2 2 , 2 0 2 2 | A S C R S A N N UA L M E E T I N G DAILY NEWS E yeWorld spoke to ASCRS President Richard Hoffman, MD, about his time as president, the challenges faced, goals, and more. EyeWorld: This past year has con- tinued to see challenges from the pandemic for ophthalmologists both on the personal and professional levels as well as for the society and the medical community as a whole; can you speak to that? How have physicians and the society adapted to move forward? Dr. Hoffman: The initial challenges from the COVID-19 pandemic have, for the most part, been alleviated with masking, social distancing, slit lamp screens, and temperature and symp- tom screenings within our practice. Although we are not back to 100% patient volume, we are close, and as the pandemic eases, things should return to normal in most practices. One of the things that struck me during the pandemic was how reliant all medical societies are on their annual meetings, and ASCRS is no different. The Annual Meeting is the life blood of our organi- zation, and although we were able to maintain the education and sharing of resources with a virtual meeting and other outreach, the virtual education was no substitute for a live, in-person gathering. D ouglas Rhee, MD, will become the president of ASCRS at the Opening General Session. He spoke with EyeWorld about his thoughts on the current and future state of the society and his insights on the field of ophthalmology as a whole. EyeWorld: How and when did you first become involved with ASCRS? continued on page 4 continued on page 3 EXPERIENCE DEXTENZA © 2022 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0411 LEARN MORE AT DEXTENZA.COM VISIT BOOTH 1315 Now Oering Our First FDA Approved Drug 09/2021 US-DEX-2100225 DEXYCU, the DEXYCU logo, and the EyePoint logo are registered trademarks of EyePoint Pharmaceuticals, Inc. ©2022 EyePoint Pharmaceuticals, Inc. All rights reserved. 480 Pleasant Street, Suite B300, Watertown, MA 02472 ImprimisRx is a registered trademark of Harrow Health Inc. ©2022 ImprimisRx, Inc. All Rights Reserved. IMPO0555Rev1 03/22 12264 1000 Aviara Pkwy, Suite 220 Carlsbad, CA 92011 Booth #2001 Visit us at ASCRS Outgoing ASCRS President Richard Hoffman, MD, discusses his time as president Interview with incoming ASCRS President Douglas Rhee, MD Dr. Rhee: I first started coming to the ASCRS Annual Meeting in 1999. I was a senior resident. It happened to be in Philadelphia, and that's where I was doing my residency, so I decided to check it out. I became involved with the organization itself when I was invit- ed by Reay Brown, MD, to serve on the Glaucoma Clinical Committee in 2006. EyeWorld: Over this time, what drove your continued engagement with ASCRS? Friday, April 22, 2022 ASCRS Annual Meeting Find ASCRS and EyeWorld on social media u

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld Daily News - 2022 EyeWorld Daily News Friday